About STAAR Surgical Company
STAAR Surgical Company (NASDAQ:STAA) specializes in developing, manufacturing, and marketing implantable lenses for the eye and delivery systems used to insert these lenses. Focused on innovation within the ophthalmic industry, STAAR aims to improve visual outcomes for patients with refractive errors. Their flagship products include the Visian ICL (Implantable Collamer® Lens), a leading alternative for correcting vision, and the Preloaded Injector, a device designed to enhance the safety and efficiency of lens implantation during surgery. STAAR Surgical's objectives center around expanding their global footprint, investing in research and development to advance their current product lineup, and providing eye care professionals with effective solutions to address a wide range of visual impairments. With a commitment to quality and patient satisfaction, STAAR continues to strive for excellence within the field of ophthalmic surgery.
Snapshot
Operations
Produtos e/ou serviços de STAAR Surgical Company
- Implantable Collamer Lenses (ICL) offer vision correction for myopia, hyperopia, and astigmatism, designed to provide high-quality vision.
- EVO Visian ICL, an advanced version of ICL, enhances night vision and reduces the need for corrective lenses.
- Preloaded Injector Systems for ICLs ensure safer, more efficient lens implantation during surgery.
- Aphakic Coloboma Lenses cater to patients lacking natural lenses due to surgery or congenital conditions, offering customized vision correction.
- Toric ICLs specifically address astigmatism, providing sharp, clear vision by correcting irregular corneal shape.
- myopia correction solutions including lenses and related technologies tailored for patients seeking alternatives to traditional vision correction methods.
equipe executiva do STAAR Surgical Company
- Mr. Stephen C. Farrell CFAChief Executive Officer
- Mr. Warren FoustPresident & COO
- Mr. Nathaniel B. Sisitsky Esq.Senior VP, Chief Legal Officer, General Counsel & Corporate Secretary
- Mr. Thomas G. FrinziAdvisor
- Dr. Magda Michna Ph.D.Chief Development Officer
- Ms. Deborah J. AndrewsChief Financial Officer
- Ms. Nancy SabinChief Marketing Officer
- Dr. Scott D. Barnes M.D.Chief Medical Officer